reports hero background
UPDATED: Nov 11, 2025

Stock Analysis

ISRG Logo
$576.20
$16.20 |2.89%
Day Range:
$560.00 - $578.30
Market Cap:
204.57B
P/E Ratio:
76.2169
Avg Value:
$520.50
Year Range:
$425.00 - $616.00
1
General Information
Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery.

It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 10,000 da Vinci systems in hospitals worldwide, with more than 6,000 installations in the US and a growing number in emerging markets.

2
Intuitive Surgical (ISRG) Stock Graph
3
How We Grade Intuitive Surgical (ISRG)

We grade stocks based on past performance, their future growth potential, intrinsic value, dividend history, and overall financial health.

The chart below shows how we grade Intuitive Surgical (ISRG) across the board compared to its closest peers.

4
Benzinga Edge Rankings

Benzinga Edge stock rankings give you four critical scores to help you identify the strongest and weakest stocks to buy and sell.

73.74

Growth measures a stock's combined historical expansion in earnings and revenue across multiple time periods, with emphasis on both long-term trends and recent performance.

7.63

Value is a percentile-ranked composite metric that evaluates a stock's relative worth by comparing its market price to fundamental measures of the company's assets, earnings, sales, and operating performance.

Momentum measures a stock's relative strength based on its price movement patterns and volatility over multiple timeframes, ranked as a percentile against other stocks.

71.39

Quality is a composite ranking that evaluates a company's operational efficiency and financial health by analyzing historical profitability metrics and fundamental strength indicators on a percentile basis relative to peers.

Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
5
Peer Ratings

See how Intuitive Surgical compares to its peers in these key performance metrics from Benzinga Rankings.

Top Peers
Value
Quality
Growth
Momentum
Short
Medium
Long
ABTAbbott Laboratories
43.28
60.34
92.73
40.62
BSXBoston Scientific
11.2
57.28
52.74
48.43
SYKStryker
14.96
56.16
94.43
26.82
MDTMedtronic
20.9
67.28
72.92
54.14
Short: price trend over the last couple of months
Medium: price trend over the last couple of quarters
Long: price trend over the past year
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
6
Future Growth
Our estimate of future price growth is based on an aggregation of 12 analyst ratings over the past 3 months and their 12-month price targets.

Below, you can see that analysts are estimating a 12-month price target range of $450.00 - $625.00 with an average of $578.08

0.17%
Expected movement for Intuitive Surgical (ISRG) over the next 12 months
Based on these rankings

Recent Ratings for Intuitive Surgical (ISRG)

UBS
Date:
Oct 23, 2025
Action:
Maintains
Prev. Target:
$585.00
New Target:
$600.00
Raymond James
Date:
Oct 22, 2025
Action:
Maintains
Prev. Target:
$592.00
New Target:
$603.00
Piper Sandler
Date:
Oct 22, 2025
Action:
Reiterates
Prev. Target:
$595.00
New Target:
$610.00
RBC Capital
Date:
Oct 22, 2025
Action:
Maintains
Prev. Target:
$615.00
New Target:
$625.00
Truist Securities
Date:
Oct 22, 2025
Action:
Maintains
Prev. Target:
$525.00
New Target:
$620.00
Wells Fargo
Date:
Oct 22, 2025
Action:
Maintains
Prev. Target:
$599.00
New Target:
$600.00
BTIG
Date:
Oct 22, 2025
Action:
Maintains
Prev. Target:
$529.00
New Target:
$589.00
Truist Securities
Date:
Oct 15, 2025
Action:
Maintains
Prev. Target:
$600.00
New Target:
$525.00
BTIG
Date:
Oct 13, 2025
Action:
Maintains
Prev. Target:
$571.00
New Target:
$529.00
7
Valuation

Earnings History (3 years)

It is important to look at a companies earnings history to see not only if they are profitable, but if their earnings are growing.
As you can see from the chart above, ISRG's earnings have increased for the past three years, this is a positive sign for the stock.
8
Financial Health
What is the current state of the company's financial situation?

We measure the health of a company based on how profitable they are and their ability to cover both their short-term and long-term debts. The key indicators that we use are the Operating Margin, Quick Ratio, and Debt-to-Equity ratio relative to the companies peers

Operational Margin 0.3033

The operating margin measures how much profit a company makes after it spends money on wages, materials or other administrative expenses but before interest and taxes. It is a good representation of how efficiently a company is able to generate profit from its core operations.

Quick Ratio 3.4897

The quick ratio measures how much of a company's debt, that is due in less than 1 year, can be covered using its cash equivalents, marketable securities, and money that is currently owed to them (accounts receivables).

A company with a quick ratio of less than 1.00 does not, in many cases, have the capital on hand to meet its short-term obligations if they were all due at once, while a quick ratio greater than one indicates the company has the financial resources to remain solvent in the short term.

Debt-to-Equity 0.1364

Debt-to-equity is calculated by dividing a company's total liabilities by its shareholders equity. It is a measure of the degree to which a company is financing its operations through debt versus wholly owned funds. Generally speaking, a D/E ratio below 1.0 would be seen as relatively safe, whereas ratios of 2.0 or higher would be considered risky.

The chart above shows Intuitive Surgical (ISRG) operating margin, quick ratio, and debt-to-equity ratio compared to its peers. The black markers represent the peer averages for each ratio and the blue bars represent Intuitive Surgical (ISRG) ratio values.
9
Past Performance
How has Intuitive Surgical (ISRG) performed over the past 5 years?

The two main factors that we consider when analyzing past performance is overall return and volatility

Using these two metrics, we can determine if this stock gave its investors enough return for the risk that they took on by owning it. This is measured by the sharpe ratio, which has been used as a primary measure of risk/reward trade-off for almost 60 years.

This ratio can be interpreted as the amount of return an investor has received for the amount of risk that they took on by owning the stock over that timeframe.

Intuitive Surgical (ISRG) sharpe ratio over the past 5 years is 1.3102 which is considered to be above average compared to the peer average of -0.1075

10
Analyzing Intuitive Surgical (ISRG) Recent Options Activity
Below, you can see the trend in options sentiment over the past 30 days.

Based on our data, ISRG's options trades have recently carried more negative sentiment than positive.

11
Company Financials
INCOME STATEMENT
The income statement also known as the profit and loss statement, primarily focuses on the company's revenues and expenses during a particular period.

The main purpose of an income statement is to convey details of profitability and business activities. Below, is ISRG's income statement for the previous four years along with its trailing-twelve- month profit & loss.

FISCAL YEAR (BIL.)
2021 ($)
2022 ($)
2023 ($)
2024 ($)
TTM ($)
Total Revenue
5.71
6.22
7.12
8.35
9.61
Operating Revenue
5.71
6.22
7.12
8.35
9.61
Cost Of Revenue
1.75
2.03
2.39
2.72
3.23
Gross Profit
3.96
4.20
4.73
5.63
6.38
Operating Expense
2.14
2.62
2.96
3.29
3.56
Selling General And Administration
1.47
1.74
1.96
2.14
2.31
Research and Development
0.67
0.88
1.00
1.15
1.25
Operating Income
1.82
1.58
1.77
2.35
2.82
Net Non-Operating Interest Income Expense
0.07
0.03
0.19
0.32
0.35
Other Income Expense
0.00
0.00
0.00
0.00
0.00
Other Non-Operating Income Expenses
0.00
0.00
0.00
0.00
0.00
Pre-Tax Income
1.89
1.61
1.96
2.67
3.17
Tax Provision
0.16
0.26
0.14
0.34
0.40
Net Income
1.70
1.32
1.80
2.32
2.75
Net Income Common Stockholders
1.70
1.32
1.80
2.32
2.75
Total Operating Income As Reported
1.82
1.58
1.77
2.35
2.82
Total Expenses
3.89
4.65
5.36
6.00
6.80
Net Income From Continuing And Discontinued Operation
1.70
1.32
1.80
2.32
2.75
Normalized Income
1.70
1.32
1.80
2.32
2.75
Interest Income
0.07
0.03
0.19
0.32
0.35
Interest Expense
0.00
0.00
0.00
0.00
0.00
Net Interest Income
0.07
0.03
0.19
0.32
0.35
EBIT
1.82
1.58
1.77
2.35
2.82
EBITDA
2.13
1.94
2.19
2.81
3.40
Reconciled Cost Of Revenue
1.75
2.03
2.39
2.72
3.23
Reconciled Depreciation
0.31
0.37
0.42
0.46
0.58
Normalized EBITDA
2.13
1.94
2.19
2.81
3.40
Tax Rate For Calcs
0.00
0.00
0.00
0.00
0.17
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
0.00
BALANCE SHEET
The balance sheet is a snapshot of a companies financials during a particular period in time.

It breaks down what company owns (assets) and what a company owes (liabilities), in order to give investors an overview of its capital structure.

FISCAL YEAR (BIL.)
2021 ($)
2022 ($)
2023 ($)
2024 ($)
TTM ($)
Total Assets
13.55
12.97
15.44
18.74
19.35
Current Assets
5.84
6.25
7.89
7.11
8.53
Total Non-Current Assets
7.71
6.72
7.55
11.63
10.83
Total Liabilities Net Minority Interest
1.60
1.86
2.04
2.21
2.31
Current Liabilities
1.15
1.42
1.66
1.75
1.80
Other Non-Current Liabilities
0.01
0.11
0.11
0.18
0.20
Total Equity Gross Minority Interest
11.95
11.11
13.40
16.53
17.04
Stockholders Equity
0.00
0.00
0.00
0.00
0.00
Total Capitalization
11.90
11.04
13.31
16.43
16.93
Common Stock Equity
11.90
11.04
13.31
16.43
16.93
Net Tangible Assets
11.49
10.64
12.92
16.06
16.57
Working Capital
4.70
4.83
6.23
5.37
6.72
Invested Capital
11.90
11.04
13.31
16.43
16.93
Tangible Book Value
11.49
10.64
12.92
16.06
16.57
Total Debt
0.09
0.00
0.00
0.00
0.00
Net Debt
0.00
0.00
0.00
0.00
0.00
Share Issued
0.36
0.35
0.35
0.36
0.35
Ordinary Shares Number
0.36
0.35
0.35
0.36
0.35
CASH FLOW STATEMENTS
A companies statement of cash flows gives an investor a break down of the cash inflows and outflows from a companies operations and investment activities.
FISCAL YEAR (BIL.)
2021 ($)
2022 ($)
2023 ($)
2024 ($)
TTM ($)
Cash Flow from Continuing Operating Activities
2.09
1.49
1.81
2.42
2.96
Net Income from Continuing Operations
1.73
1.34
1.82
2.34
2.77
Depreciation and Amortization
0.31
0.37
0.42
0.46
0.58
Deferred Tax
-0.06
-0.19
-0.28
-0.14
0.03
Deferred Income Tax
-0.06
-0.19
-0.28
-0.14
0.03
Stock-Based Compensation
0.45
0.51
0.59
0.68
0.76
Other Non-Cash Items
0.02
0.03
0.03
0.04
0.04
Change in Working Capital
-0.37
-0.62
-0.78
-0.92
-1.16
Change in Receivables
-0.14
-0.16
-0.19
-0.10
-0.11
Changes in Account Receivables
-0.14
-0.16
-0.19
-0.10
-0.11
Change in Inventory
-0.26
-0.55
-0.71
-0.83
-0.99
Change in Payables and Accrued Expense
0.04
0.02
0.04
Change in Payable
0.04
0.02
0.04
0.08
Change in Account Payable
0.04
0.02
0.04
0.08
Change in Other Current Assets
Change in Other Current Liabilities
0.05
0.12
-0.03
0.11
0.10
Change in Other Working Capital
0.15
0.07
0.09
0.13
0.24
Cash Flow from Continuing Investing Activities
-2.46
1.37
-0.36
-3.27
-0.39
Net PPE Purchase and Sale
-0.35
-0.53
-1.06
-1.11
-0.69
Net Business Purchase and Sale
-0.01
-0.01
-0.01
Purchase of Business
-0.01
-0.01
-0.01
Net Investment Purchase and Sale
-2.10
1.92
0.71
-2.16
0.30
Purchase of Investment
-6.45
-1.40
-2.21
-5.14
-2.22
Sale of Investment
4.35
3.32
2.92
2.98
2.52
Net Other Investing Changes
Financing Cash Flow
0.04
-2.57
-0.29
0.15
-2.18
Cash Flow from Continuing Financing Activities
0.04
-2.57
-0.29
0.15
-2.18
Net Issuance Payments of Debt
Net Long-Term Debt Issuance
Long-Term Debt Issuance
Long-Term Debt Payments
Net Short-Term Debt Issuance
Net Common Stock Issuance
-2.61
-0.42
Common Stock Issuance
Common Stock Payments
-2.61
-0.42
Cash Dividends Paid
Net Other Financing Charges
-0.23
-0.20
-0.17
-0.28
-0.42
End Cash Position
5.72
5.82
12.02
10.44
10.98
Changes in Cash
-0.33
0.29
1.17
-0.71
0.39
Beginning Cash Position
6.05
5.53
10.85
11.15
10.57
Capital Expenditure
-0.35
-0.53
-1.06
-1.11
-0.69
Issuance of Capital Stock
Issuance of Debt
Repayment of Debt
Repurchase of Capital Stock
-2.61
-0.42
Free Cash Flow
1.74
0.96
0.75
1.30
2.27